Michael Lenardo is Chief of Molecular Development of the Immune System Section at the National Institute of Allergy and Infectious Diseases in the USA. He is a leading American Immunologist who has made an important contribution to UK medical science through his creation in 2000 of the NIH Oxford and Cambridge Scholars Program. This charity-supported program has resulted in over 220 graduates conducting research in the UK. His research has led to the discovery of various novel genetic mechanisms of immunological diseases, including the first genetic disease of apoptosis due to mutations in CD95 and other apoptosis genes.
Fellow
Back to directory listingDr Michael Lenardo OBE FMedSci
Job Title
Chief, Molecular Development of the Immune System Section and Director Clinical Genomics Program National Institute of Allergy and Infectious Diseases
Department
Laboratory of Immune System Biology
Institution
National Institute of Allergy and Infectious Diseases
Year elected
2020
Interests
SpecialitiesGenetic diseases of immune function, regulation, and homeostasis and autoimmunity; apoptotic and non-apoptotic mechanisms of cell death; development of novel immunodiagnostics and immunotherapeutics
Section committee elected byCellular and developmental biology, microbiology and immunology, genetics
Online Information